
Magdalene K. Sgagias
Examiner (ID: 4537, Phone: (571)272-3305 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632 |
| Total Applications | 637 |
| Issued Applications | 229 |
| Pending Applications | 42 |
| Abandoned Applications | 366 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5453221
[patent_doc_number] => 20090069258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'RECOMBINANT ANTIBODIES SPECIFIC FOR BETA-AMYLOID ENDS, DNA ENCODING AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/745759
[patent_app_country] => US
[patent_app_date] => 2007-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13232
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20090069258.pdf
[firstpage_image] =>[orig_patent_app_number] => 11745759
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/745759 | RECOMBINANT ANTIBODIES SPECIFIC FOR BETA-AMYLOID ENDS, DNA ENCODING AND METHODS OF USE THEREOF | May 7, 2007 | Abandoned |
Array
(
[id] => 4826845
[patent_doc_number] => 20080125389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'Men1 is a marker and therapeutic target for breast and prostate cancer'
[patent_app_type] => utility
[patent_app_number] => 11/800272
[patent_app_country] => US
[patent_app_date] => 2007-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13070
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20080125389.pdf
[firstpage_image] =>[orig_patent_app_number] => 11800272
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/800272 | Men1 is a marker and therapeutic target for breast and prostate cancer | May 2, 2007 | Abandoned |
Array
(
[id] => 5046884
[patent_doc_number] => 20070265558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'STEM CELLS DERIVED FROM BONE MARROW FOR TISSUE REGENERATION'
[patent_app_type] => utility
[patent_app_number] => 11/742944
[patent_app_country] => US
[patent_app_date] => 2007-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10040
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20070265558.pdf
[firstpage_image] =>[orig_patent_app_number] => 11742944
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/742944 | Stem cells derived from bone marrow for tissue regeneration | Apr 30, 2007 | Issued |
Array
(
[id] => 5428547
[patent_doc_number] => 20090087857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-02
[patent_title] => 'Molecular Beacons for DNA-Photography'
[patent_app_type] => utility
[patent_app_number] => 12/298044
[patent_app_country] => US
[patent_app_date] => 2007-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6962
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20090087857.pdf
[firstpage_image] =>[orig_patent_app_number] => 12298044
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/298044 | Molecular Beacons for DNA-Photography | Apr 25, 2007 | Abandoned |
Array
(
[id] => 6615930
[patent_doc_number] => 20100003222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'METHODS FOR BONE REGENERATION USING ENDOTHELIAL PROGENITOR CELL PREPARATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/297417
[patent_app_country] => US
[patent_app_date] => 2007-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8360
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20100003222.pdf
[firstpage_image] =>[orig_patent_app_number] => 12297417
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/297417 | Methods for bone regeneration using endothelial progenitor cell preparations | Apr 16, 2007 | Issued |
Array
(
[id] => 5085415
[patent_doc_number] => 20070275466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'Methods of modifying genes in eukaryotic cells'
[patent_app_type] => utility
[patent_app_number] => 11/787969
[patent_app_country] => US
[patent_app_date] => 2007-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9408
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20070275466.pdf
[firstpage_image] =>[orig_patent_app_number] => 11787969
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/787969 | Methods of modifying genes in eukaryotic cells | Apr 16, 2007 | Abandoned |
Array
(
[id] => 5070197
[patent_doc_number] => 20070191299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Extension Of The Expression of Transgenic Proteins By Immunomodulation'
[patent_app_type] => utility
[patent_app_number] => 11/696782
[patent_app_country] => US
[patent_app_date] => 2007-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3224
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191299.pdf
[firstpage_image] =>[orig_patent_app_number] => 11696782
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/696782 | Extension Of The Expression of Transgenic Proteins By Immunomodulation | Apr 4, 2007 | Abandoned |
Array
(
[id] => 5409468
[patent_doc_number] => 20090123366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'Targeted Therapy'
[patent_app_type] => utility
[patent_app_number] => 12/293452
[patent_app_country] => US
[patent_app_date] => 2007-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10331
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20090123366.pdf
[firstpage_image] =>[orig_patent_app_number] => 12293452
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/293452 | Targeted Therapy | Apr 2, 2007 | Abandoned |
Array
(
[id] => 4670411
[patent_doc_number] => 20080045471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'Nucleic Acids For Apoptosis Of Cancer Cells'
[patent_app_type] => utility
[patent_app_number] => 11/691994
[patent_app_country] => US
[patent_app_date] => 2007-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 22315
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20080045471.pdf
[firstpage_image] =>[orig_patent_app_number] => 11691994
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/691994 | Nucleic Acids For Apoptosis Of Cancer Cells | Mar 26, 2007 | Abandoned |
Array
(
[id] => 4845461
[patent_doc_number] => 20080181869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'THERAPEUTICS TO FACILITATE CELL TRANSPLANTATION FOR LIVER DISEASE'
[patent_app_type] => utility
[patent_app_number] => 11/684808
[patent_app_country] => US
[patent_app_date] => 2007-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15508
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20080181869.pdf
[firstpage_image] =>[orig_patent_app_number] => 11684808
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/684808 | THERAPEUTICS TO FACILITATE CELL TRANSPLANTATION FOR LIVER DISEASE | Mar 11, 2007 | Abandoned |
Array
(
[id] => 6282070
[patent_doc_number] => 20100257617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'Transgenic animals comprising gene fusions'
[patent_app_type] => utility
[patent_app_number] => 11/708858
[patent_app_country] => US
[patent_app_date] => 2007-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 85
[patent_figures_cnt] => 85
[patent_no_of_words] => 47247
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11708858
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/708858 | Transgenic animals comprising gene fusions | Feb 20, 2007 | Abandoned |
Array
(
[id] => 5507962
[patent_doc_number] => 20090081169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'METHOD FOR OSTEOGENIC DIFFERENTIATION OF BONE MARROW STEM CELLS (BMSC) AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/278557
[patent_app_country] => US
[patent_app_date] => 2007-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 21625
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081169.pdf
[firstpage_image] =>[orig_patent_app_number] => 12278557
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/278557 | Method for osteogenic differentiation of bone marrow stem cells (BMSC) and uses thereof | Feb 15, 2007 | Issued |
Array
(
[id] => 5943507
[patent_doc_number] => 20110104127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'mRNA-TRANSFECTION OF ADULT PROGENITOR CELLS FOR SPECIFIC TISSUE REGENERATION'
[patent_app_type] => utility
[patent_app_number] => 12/278952
[patent_app_country] => US
[patent_app_date] => 2007-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2731
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20110104127.pdf
[firstpage_image] =>[orig_patent_app_number] => 12278952
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/278952 | mRNA-TRANSFECTION OF ADULT PROGENITOR CELLS FOR SPECIFIC TISSUE REGENERATION | Feb 7, 2007 | Abandoned |
Array
(
[id] => 4979385
[patent_doc_number] => 20070220620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'TAT-046 and methods of assessing and treating cancer'
[patent_app_type] => utility
[patent_app_number] => 11/700590
[patent_app_country] => US
[patent_app_date] => 2007-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 64716
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20070220620.pdf
[firstpage_image] =>[orig_patent_app_number] => 11700590
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/700590 | TAT-046 and methods of assessing and treating cancer | Jan 30, 2007 | Abandoned |
Array
(
[id] => 5006778
[patent_doc_number] => 20070204351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Direct differentiation of cardiomyocytes from human embryonic stem cells'
[patent_app_type] => utility
[patent_app_number] => 11/644790
[patent_app_country] => US
[patent_app_date] => 2006-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 17393
[patent_no_of_claims] => 74
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20070204351.pdf
[firstpage_image] =>[orig_patent_app_number] => 11644790
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/644790 | Direct differentiation of cardiomyocytes from human embryonic stem cells | Dec 21, 2006 | Abandoned |
Array
(
[id] => 141967
[patent_doc_number] => 07687474
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-30
[patent_title] => 'Nitroreductase enzymes'
[patent_app_type] => utility
[patent_app_number] => 11/643628
[patent_app_country] => US
[patent_app_date] => 2006-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14001
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/687/07687474.pdf
[firstpage_image] =>[orig_patent_app_number] => 11643628
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/643628 | Nitroreductase enzymes | Dec 19, 2006 | Issued |
| 10/575872 | Regenerative Medical Treatment System | Dec 17, 2006 | Abandoned |
Array
(
[id] => 10142459
[patent_doc_number] => 09175261
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-03
[patent_title] => 'Human umbilical cord tissue cells for inhibiting adverse immune response in histocompatibility-mismatched transplantation'
[patent_app_type] => utility
[patent_app_number] => 11/611602
[patent_app_country] => US
[patent_app_date] => 2006-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 32419
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11611602
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/611602 | Human umbilical cord tissue cells for inhibiting adverse immune response in histocompatibility-mismatched transplantation | Dec 14, 2006 | Issued |
Array
(
[id] => 5034164
[patent_doc_number] => 20070098703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Methods for Using Adipose-Derived Cells for Healing of Aortic Aneurysmal Tissue'
[patent_app_type] => utility
[patent_app_number] => 11/564715
[patent_app_country] => US
[patent_app_date] => 2006-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4801
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20070098703.pdf
[firstpage_image] =>[orig_patent_app_number] => 11564715
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/564715 | Methods for Using Adipose-Derived Cells for Healing of Aortic Aneurysmal Tissue | Nov 28, 2006 | Abandoned |
Array
(
[id] => 5538662
[patent_doc_number] => 20090220467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'USE OF TYPE II PNEUMOCYTES IN THE TREATMENT OF PULMONARY DISEASES ASSOCIATED WITH PULMONARY FIBROSIS'
[patent_app_type] => utility
[patent_app_number] => 12/095028
[patent_app_country] => US
[patent_app_date] => 2006-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6067
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220467.pdf
[firstpage_image] =>[orig_patent_app_number] => 12095028
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/095028 | Method for using type II pneumocytes in pulmonary fibrosis | Nov 26, 2006 | Issued |